Klingelnberg AG
Klingelnberg AG (KLIN.SW) Stock Competitors & Peer Comparison
See (KLIN.SW) competitors and their performances in Stock Market.
Peer Comparison Table: Industrial - Machinery Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| KLIN.SW | CHF 10.50 | -0.94% | 92.8M | -35.00 | -CHF 0.30 | +4.76% |
| GE.SW | CHF 152.00 | +4.11% | 164.8B | 48.56 | CHF 3.13 | +0.55% |
| SCHP.SW | CHF 261.80 | +1.00% | 27.8B | 27.53 | CHF 9.46 | +2.61% |
| SCHN.SW | CHF 250.00 | +0.81% | 26.6B | 26.29 | CHF 9.47 | +2.61% |
| VACN.SW | CHF 489.40 | +3.95% | 14.5B | 67.57 | CHF 7.16 | +1.29% |
| RAA.SW | CHF 615.00 | +0.00% | 7.7B | 48.08 | CHF 12.79 | +2.08% |
| SUN.SW | CHF 168.00 | +3.83% | 5.6B | 19.18 | CHF 8.58 | +2.58% |
| KGX.SW | CHF 40.72 | -1.64% | 5.3B | 21.43 | CHF 1.90 | +1.84% |
| JUNGH.SW | CHF 30.90 | +0.00% | 3.5B | 11.61 | CHF 2.66 | +3.09% |
| BUCN.SW | CHF 351.50 | +2.18% | 3.4B | 14.97 | CHF 23.22 | +3.17% |
Stock Comparison
KLIN.SW vs GE.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, GE.SW has a market cap of 164.8B. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while GE.SW trades at CHF 152.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas GE.SW's P/E ratio is 48.56. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to GE.SW's ROE of +0.46%. Regarding short-term risk, KLIN.SW is less volatile compared to GE.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check GE.SW's competition here
KLIN.SW vs SCHP.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, SCHP.SW has a market cap of 27.8B. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while SCHP.SW trades at CHF 261.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas SCHP.SW's P/E ratio is 27.53. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to SCHP.SW's ROE of +0.21%. Regarding short-term risk, KLIN.SW is more volatile compared to SCHP.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check SCHP.SW's competition here
KLIN.SW vs SCHN.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, SCHN.SW has a market cap of 26.6B. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while SCHN.SW trades at CHF 250.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas SCHN.SW's P/E ratio is 26.29. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to SCHN.SW's ROE of +0.21%. Regarding short-term risk, KLIN.SW is less volatile compared to SCHN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check SCHN.SW's competition here
KLIN.SW vs VACN.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, VACN.SW has a market cap of 14.5B. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while VACN.SW trades at CHF 489.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas VACN.SW's P/E ratio is 67.57. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to VACN.SW's ROE of +0.29%. Regarding short-term risk, KLIN.SW is less volatile compared to VACN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check VACN.SW's competition here
KLIN.SW vs RAA.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, RAA.SW has a market cap of 7.7B. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while RAA.SW trades at CHF 615.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas RAA.SW's P/E ratio is 48.08. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to RAA.SW's ROE of +0.29%. Regarding short-term risk, KLIN.SW is more volatile compared to RAA.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check RAA.SW's competition here
KLIN.SW vs SUN.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, SUN.SW has a market cap of 5.6B. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while SUN.SW trades at CHF 168.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas SUN.SW's P/E ratio is 19.18. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to SUN.SW's ROE of +0.24%. Regarding short-term risk, KLIN.SW is less volatile compared to SUN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check SUN.SW's competition here
KLIN.SW vs KGX.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, KGX.SW has a market cap of 5.3B. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while KGX.SW trades at CHF 40.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas KGX.SW's P/E ratio is 21.43. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to KGX.SW's ROE of +0.04%. Regarding short-term risk, KLIN.SW is more volatile compared to KGX.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check KGX.SW's competition here
KLIN.SW vs JUNGH.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, JUNGH.SW has a market cap of 3.5B. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while JUNGH.SW trades at CHF 30.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas JUNGH.SW's P/E ratio is 11.61. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to JUNGH.SW's ROE of +0.10%. Regarding short-term risk, KLIN.SW is more volatile compared to JUNGH.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check JUNGH.SW's competition here
KLIN.SW vs BUCN.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, BUCN.SW has a market cap of 3.4B. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while BUCN.SW trades at CHF 351.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas BUCN.SW's P/E ratio is 14.97. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to BUCN.SW's ROE of +0.09%. Regarding short-term risk, KLIN.SW is less volatile compared to BUCN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check BUCN.SW's competition here
KLIN.SW vs KU2.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, KU2.SW has a market cap of 3.3B. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while KU2.SW trades at CHF 53.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas KU2.SW's P/E ratio is 36.60. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to KU2.SW's ROE of +0.05%. Regarding short-term risk, Volatility data is not available for a full comparison. KLIN.SW has daily volatility of 0.95 and KU2.SW has daily volatility of N/A.Check KU2.SW's competition here
KLIN.SW vs GF.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, GF.SW has a market cap of 3.3B. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while GF.SW trades at CHF 41.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas GF.SW's P/E ratio is 16.90. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to GF.SW's ROE of +1.22%. Regarding short-term risk, KLIN.SW is less volatile compared to GF.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check GF.SW's competition here
KLIN.SW vs WAF.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, WAF.SW has a market cap of 2.2B. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while WAF.SW trades at CHF 71.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas WAF.SW's P/E ratio is 6.86. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to WAF.SW's ROE of -0.04%. Regarding short-term risk, KLIN.SW is more volatile compared to WAF.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check WAF.SW's competition here
KLIN.SW vs KARN.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, KARN.SW has a market cap of 1.8B. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while KARN.SW trades at CHF 244.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas KARN.SW's P/E ratio is 47.48. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to KARN.SW's ROE of +0.16%. Regarding short-term risk, KLIN.SW is less volatile compared to KARN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check KARN.SW's competition here
KLIN.SW vs BCHN.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, BCHN.SW has a market cap of 1.6B. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while BCHN.SW trades at CHF 485.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas BCHN.SW's P/E ratio is 15.18. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to BCHN.SW's ROE of +0.36%. Regarding short-term risk, KLIN.SW is less volatile compared to BCHN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check BCHN.SW's competition here
KLIN.SW vs INRN.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, INRN.SW has a market cap of 1.2B. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while INRN.SW trades at CHF 1,512.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas INRN.SW's P/E ratio is 21.85. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to INRN.SW's ROE of +0.12%. Regarding short-term risk, KLIN.SW is less volatile compared to INRN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check INRN.SW's competition here
KLIN.SW vs BLD.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, BLD.SW has a market cap of 1.2B. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while BLD.SW trades at CHF 3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas BLD.SW's P/E ratio is -6.66. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to BLD.SW's ROE of -0.15%. Regarding short-term risk, KLIN.SW is more volatile compared to BLD.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check BLD.SW's competition here
KLIN.SW vs OERL.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, OERL.SW has a market cap of 1B. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while OERL.SW trades at CHF 3.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas OERL.SW's P/E ratio is -19.41. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to OERL.SW's ROE of -0.02%. Regarding short-term risk, KLIN.SW is less volatile compared to OERL.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check OERL.SW's competition here
KLIN.SW vs BYS.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, BYS.SW has a market cap of 431.4M. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while BYS.SW trades at CHF 212.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas BYS.SW's P/E ratio is -14.93. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to BYS.SW's ROE of -0.05%. Regarding short-term risk, KLIN.SW is less volatile compared to BYS.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check BYS.SW's competition here
KLIN.SW vs PM.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, PM.SW has a market cap of 402.4M. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while PM.SW trades at CHF 419.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas PM.SW's P/E ratio is 10.47. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to PM.SW's ROE of +0.09%. Regarding short-term risk, KLIN.SW is less volatile compared to PM.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check PM.SW's competition here
KLIN.SW vs PMN.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, PMN.SW has a market cap of 386.1M. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while PMN.SW trades at CHF 410.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas PMN.SW's P/E ratio is 13.65. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to PMN.SW's ROE of +0.09%. Regarding short-term risk, KLIN.SW is less volatile compared to PMN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check PMN.SW's competition here
KLIN.SW vs MTG.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, MTG.SW has a market cap of 379.5M. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while MTG.SW trades at CHF 35.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas MTG.SW's P/E ratio is 25.11. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to MTG.SW's ROE of +0.10%. Regarding short-term risk, KLIN.SW is less volatile compared to MTG.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check MTG.SW's competition here
KLIN.SW vs NOEJ.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, NOEJ.SW has a market cap of 367.1M. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while NOEJ.SW trades at CHF 73.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas NOEJ.SW's P/E ratio is 43.89. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to NOEJ.SW's ROE of -0.10%. Regarding short-term risk, KLIN.SW is more volatile compared to NOEJ.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check NOEJ.SW's competition here
KLIN.SW vs MEDX.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, MEDX.SW has a market cap of 351M. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while MEDX.SW trades at CHF 8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas MEDX.SW's P/E ratio is 57.53. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to MEDX.SW's ROE of +0.02%. Regarding short-term risk, KLIN.SW is less volatile compared to MEDX.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check MEDX.SW's competition here
KLIN.SW vs MIKN.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, MIKN.SW has a market cap of 279.7M. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while MIKN.SW trades at CHF 16.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas MIKN.SW's P/E ratio is 8.59. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to MIKN.SW's ROE of +0.14%. Regarding short-term risk, KLIN.SW is less volatile compared to MIKN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check MIKN.SW's competition here
KLIN.SW vs KOMN.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, KOMN.SW has a market cap of 257.3M. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while KOMN.SW trades at CHF 50.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas KOMN.SW's P/E ratio is -28.36. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to KOMN.SW's ROE of -0.02%. Regarding short-term risk, KLIN.SW is less volatile compared to KOMN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check KOMN.SW's competition here
KLIN.SW vs STGN.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, STGN.SW has a market cap of 186.3M. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while STGN.SW trades at CHF 33.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas STGN.SW's P/E ratio is 34.80. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to STGN.SW's ROE of +0.02%. Regarding short-term risk, KLIN.SW is less volatile compared to STGN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check STGN.SW's competition here
KLIN.SW vs FTON.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, FTON.SW has a market cap of 131M. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while FTON.SW trades at CHF 9.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas FTON.SW's P/E ratio is -16.48. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to FTON.SW's ROE of -0.02%. Regarding short-term risk, KLIN.SW is less volatile compared to FTON.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check FTON.SW's competition here
KLIN.SW vs RIEN.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, RIEN.SW has a market cap of 116M. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while RIEN.SW trades at CHF 3.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas RIEN.SW's P/E ratio is -2.40. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to RIEN.SW's ROE of -0.11%. Regarding short-term risk, KLIN.SW is less volatile compared to RIEN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check RIEN.SW's competition here
KLIN.SW vs TOHN.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, TOHN.SW has a market cap of 101M. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while TOHN.SW trades at CHF 5.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas TOHN.SW's P/E ratio is 8.53. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to TOHN.SW's ROE of +0.02%. Regarding short-term risk, KLIN.SW is less volatile compared to TOHN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check TOHN.SW's competition here
KLIN.SW vs STRN.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, STRN.SW has a market cap of 20.8M. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while STRN.SW trades at CHF 18.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas STRN.SW's P/E ratio is -28.92. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to STRN.SW's ROE of -0.04%. Regarding short-term risk, KLIN.SW is more volatile compared to STRN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check STRN.SW's competition here
KLIN.SW vs PEDU.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, PEDU.SW has a market cap of 5.6M. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while PEDU.SW trades at CHF 47.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas PEDU.SW's P/E ratio is -5.29. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to PEDU.SW's ROE of -0.12%. Regarding short-term risk, KLIN.SW is more volatile compared to PEDU.SW. This indicates potentially higher risk in terms of short-term price fluctuations for KLIN.SW.Check PEDU.SW's competition here
KLIN.SW vs BOBNN.SW Comparison April 2026
KLIN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KLIN.SW stands at 92.8M. In comparison, BOBNN.SW has a market cap of 0. Regarding current trading prices, KLIN.SW is priced at CHF 10.50, while BOBNN.SW trades at CHF 57.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KLIN.SW currently has a P/E ratio of -35.00, whereas BOBNN.SW's P/E ratio is N/A. In terms of profitability, KLIN.SW's ROE is -0.02%, compared to BOBNN.SW's ROE of +0.17%. Regarding short-term risk, KLIN.SW is less volatile compared to BOBNN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for KLIN.SW.Check BOBNN.SW's competition here